openPR Logo
Press release

Tendinitis Treatment Market 2019 Size, Share and Key Leaders Analysis by Almatica Pharma, Inc., AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc, Pfizer and others

04-01-2019 02:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Tendinitis Treatment Market

Tendinitis Treatment Market

Tendinitis is the inflammation of the tendon, thick cords that attach the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction. Tendinitis is found to be prevalent among athletes and is one of the common sport injuries in sport players, especially tennis, golf and others. Various pharmacological and non-pharmacological treatments are available for the treatment of tendinitis. Non-steroidal anti-inflammatory drugs (NSAIDs) constitute the preliminary treatment options. Other treatments including physical therapy, rest, and occupational therapy. Surgery is the last resort for tendinitis, and is only recommended in case of severe damage to the tendon that cannot be treated using pharmacological treatment options.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3876

Global tendinitis treatment market is expected to grow at the CAGR of ~3.8% during the forecast period and is estimated to reach USD 426.4 million by 2023. According to a recent study report published by the Market Research Future, the global tendinitis treatment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017 – 2023).

Key players for Global Tendinitis Treatment Market:

• Almatica Pharma, Inc. (US),
• AstraZeneca (US),
• Bayer (Germany),
• Boehringer Ingelheim Pharmaceuticals, Inc. (US),
• Merck & Co., Inc (US),
• Pfizer (US).

Intended Audience:

• Tendinitis medicines manufacturers
• Tendinitis medicines and treatment providers
• Medical Research laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors

Segments:

Global tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's knee, and others.

On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.

On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional analysis of global Tendinitis treatment market:

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly includes North America and South America. Due to developed healthcare infrastructure and increasing R&D funding, US is dominating country in this region. Europe is second largest market for tendinitis treatment. Due to innovative product development and rapid adoption of new treatments, Germany is dominating this market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and Africa is expected to have limited growth while Middle Eastern countries are expected to dominate this market during the forecast period.

Global Tendinitis Treatment Market - Competitive Analysis

The market for tendinitis treatment is characterised by the presence of several well-established and small players, the global market of tendinitis treatment appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The tendinitis treatment market appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Many leading players are concentrated in the Americas owing to well-established market and high healthcare expenditures; these players have expanded their market in other region as well. Furthermore, the companies such as Abbott, AstraZeneca, Teva, and Pfizer are well-established in European market. The major four players namely Abbott, AstraZeneca, Teva, and Pfizer accounted for more than 17% share of the Americas and Europe tendinitis market.

In April 2017, Pfizer entered into a merger with Allergan to gain access for Allergan's portfolio including Botox, Viagra, the Prevnar pneumonia vaccine, and treatments for ailments including Alzheimer’s and rheumatoid arthritis.

Furthermore, in July 2017, Merck & Co.Inc & AstraZeneca entered into strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s LYNPARZA (olaparib) for multiple cancer types.

Furthermore, in November 2016, AstraZeneca announced a licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc., for the global rights to MEDI2070.

Moreover, May 2014, the company acquired Merck & Co., Inc.’s non-prescription business to become the OTC leader in North America and Latin America & achieve top global positions in key OTC product categories.

Therefore, the growing key business strategies will help the key competitors to expand their presence in various parts of the globe for their competitive products and will has spurred the growth of the market.

Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/tendinitis-treatment-market-3876

Detailed Table of Contents:

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

11. Competitive Landscape

12. Company Profile

13. Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Tendinitis Treatment Market

14. Appendix

...TOC Continued!

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3876

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tendinitis Treatment Market 2019 Size, Share and Key Leaders Analysis by Almatica Pharma, Inc., AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc, Pfizer and others here

News-ID: 1681538 • Views: 337

More Releases from Market Research Future

Medical Aesthetics Industry Size, Market Growth, Key Company Profile, Comprehens …
The “Global Medical Aesthetics Market Is Showing High Probabilities Of Achieving A CAGR Of 11% Between 2018 And 2023”. Medical aesthetics Industry covers the aesthetical aspect of the healthcare sector and includes well-being, noticeable skin changes, peripheral appearance, and image of the patient. Medical aesthetics include fuses beauty and healthcare services and are getting substantial traction not just from demand for upliftment of the looks but anti-aging as well. There are several
Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to

All 5 Releases


More Releases for Tendinitis

Tendinitis Treatment Market 2018 Structure | Along with Abbott, Pfizer, AstraZen …
Market Research Future announced a research report on “Tendinitis Treatment Market”. Tendinitis Treatment Market is expected to grow at a Huge Rate by 2023. Along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Tendinitis Treatment Market Highlights: Tendinitis is an inflammatory disease causing damage to the tendon leading to pain and
Tendinitis Treatment Market Flourishes Key Players Share, Revenue, Demand and Fo …
Market Synopsis of the Americas & Europe Tendinitis Treatment Market:              Tendinitis is the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear
Meningitis Diagnosis Market Overview of Tendinitis Treatment Market Clinical Tri …
Synopsis: Meningitis is a disease characterized by inflammation of meninges, the membranes surrounding the brain, and spinal cord. A headache, fever, sleepiness, lethargy, nausea, decreased appetite, and a stiff neck are the triggers of meningitis. Viral and bacterial infections are the common causes of meningitis. Other causes are fungi, cancer, drug allergies, and chemical irritation. Bacterial and viral can be transmitted by coughing, sneezing, or close contact. Meningitis is of three
Tendinitis Treatment Market SWOT Analysis, Key Players, Analysis and Forecasts T …
Market Synopsis of the Americas & Europe Tendinitis Treatment Market: Tendinitis is the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction.
Americas & Europe tendinitis treatment market is expected to grow at a CAGR of 7 …
Market Research Future has a cooked research report on the Americas & Europe tendinitis treatment market. The Americas & Europe tendinitis treatment market is growing continuously and expected to grow at a CAGR of 7.2% from 2017 to 2023. Tendinitis is an inflammatory disease causing damage to the tendon leading to pain and tenderness of the tendon. The most common causes of tendinitis are sudden injury, strain, exertion, repetitive movement, and
Tendinitis Treatment Market Research Report - Global Forecast till 2023
Global Tendinitis Treatment Market is expected to grow at the CAGR of ~3.8% during the forecast period and is estimated to reach USD 426.4 million by 2023. Key players for Tendinitis Treatment Market: Some of the